
Precipio PRPO
€ 28.14
1.96%
Geschäftsbericht 2025
hinzugefügt 30.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
1.61 M |
Marktkapitalisierung |
$ 53 M |
EBITDA (LTM) |
$ -7.34 M |
P/E (LTM) |
-32.05 |
P/S (LTM) |
2.3 |
EPS (LTM) |
-1.01 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 16.16 | -5.08 % | $ 170 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 117.77 | 0.2 % | $ 35.8 B | NYSE,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 20.76 | 0.28 % | $ 1.11 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 1.54 | -3.14 % | $ 2.05 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 24.37 | -0.93 % | $ 677 M | Nasdaq Global Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 186.25 | 0.46 % | $ 9.23 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 15.19 | 1.95 % | $ 459 M | Nasdaq Global Market | ||
|
Medpace Holdings
MEDP
|
$ 431.05 | 0.17 % | $ 12.4 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.03 | -19.98 % | $ 373 M | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 8.48 | -4.29 % | $ 1.09 B | Nasdaq Global Select Market,SPB | ||
|
Guardant Health
GH
|
$ 88.89 | -0.7 % | $ 11.1 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.8 | 0.29 % | $ 421 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 207.6 | 0.4 % | $ 20.4 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.06 | 2.31 % | $ 20 B | NYSE | ||
|
Personalis
PSNL
|
$ 5.73 | 3.05 % | $ 340 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 123.33 | 1.66 % | $ 10.2 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 138.82 | -0.18 % | $ 22.1 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 5.01 | 0.1 % | $ 209 M | NYSE American | ||
|
Interpace Biosciences
IDXG
|
$ 2.01 | 0.4 % | $ 8.89 M | Nasdaq Global Select Market | ||
|
Soleno Therapeutics
SLNO
|
$ 52.9 | -0.04 % | $ 2.69 B | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Biomerica
BMRA
|
$ 2.2 | 0.69 % | $ 5.05 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 86.5 | 0.79 % | $ 5.84 B | Nasdaq Global Select Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 468.18 | 0.3 % | $ 177 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 255.31 | -0.71 % | $ 21.2 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.6 | 0.47 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 58.62 | 3.39 % | $ 3.51 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 137.75 | -2.78 % | $ 6.44 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.25 | -0.22 % | $ 2.01 B | Nasdaq Global Select Market,SPB | ||
|
Waters Corporation
WAT
|
$ 345.28 | 0.74 % | $ 20.6 B | NYSE,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 190.06 | -0.41 % | $ 21.1 B | NYSE,SPB |